Prevalence of Optimal HbA1c Levels in Type 2 Diabetes Mellitus Patients under Antidiabetic Treatment: A Cross-Sectional Study

Objective: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic disorder. Achieving stable, optimal HbA1C levels is crucial for managing T2DM. The objective of our current study is to determine the prevalence of controlled HbA1C levels among individuals who are diagnosed with T2DM and receiving antidiabetic medications.Materials and Methods: Adult patients with T2DM and under antidiabetic medications enrolled in our study. From March 2023 to February 2024, 196 patients were recruited in this study. Data on demographic and clinical information extracted from the patient's records and HbA1C levels were measured. The association between different factors and the achievement of optimal HbA1C levels was evaluated among participants.Results: Males achieved optimal HbA1c levels more frequently than females (80.2% vs 78.5). Regarding the type of medication, participants with oral medications represented glycemic control 55%, compared to 45% in those receiving injectable drugs. Moreover, we observed an inverse association between the duration of diabetes onset and glycemic control status. Our study showed no significant differences in the prevalence of controlled HbA1C levels based on age (P= 0.087), gender (P= 0.930), diabetes duration (P= 0.660), and medication type (P= 0.376).Conclusion: Most of the patients with T2DM who were receiving antidiabetic medications achieved optimal HbA1C levels. It is recommended that additional education and support programs be provided to improve diabetes control and reduce its complications.

Authors

Institutions

Publication Details

Journal
Iranian journal of diabetes and obesity
Published
2026-11-17
DOI
https://doi.org/10.18502/ijdo.v18i4.23242
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prevalence of Optimal HbA1c Levels in Type 2 Diabetes Mellitus Patients under Antidiabetic Treatment: A Cross-Sectional Study

Maryam Shiehmorteza, Alireza Arefzadeh, Paria Babaahmadi, Ghazal Shahriari
1 links
Iranian journal of diabetes and obesity
Diabetes Treatment and Management
article

Prevalence of Optimal HbA1c Levels in Type 2 Diabetes Mellitus Patients under Antidiabetic Treatment: A Cross-Sectional Study

Maryam Shiehmorteza, Alireza Arefzadeh, Paria Babaahmadi, Ghazal Shahriari
article en

Abstract

Objective: Type 2 Diabetes Mellitus (T2DM) is a prevalent chronic disorder. Achieving stable, optimal HbA1C levels is crucial for managing T2DM. The objective of our current study is to determine the prevalence of controlled HbA1C levels among individuals who are diagnosed with T2DM and receiving antidiabetic medications.Materials and Methods: Adult patients with T2DM and under antidiabetic medications enrolled in our study. From March 2023 to February 2024, 196 patients were recruited in this study. Data on demographic and clinical information extracted from the patient's records and HbA1C levels were measured. The association between different factors and the achievement of optimal HbA1C levels was evaluated among participants.Results: Males achieved optimal HbA1c levels more frequently than females (80.2% vs 78.5). Regarding the type of medication, participants with oral medications represented glycemic control 55%, compared to 45% in those receiving injectable drugs. Moreover, we observed an inverse association between the duration of diabetes onset and glycemic control status. Our study showed no significant differences in the prevalence of controlled HbA1C levels based on age (P= 0.087), gender (P= 0.930), diabetes duration (P= 0.660), and medication type (P= 0.376).Conclusion: Most of the patients with T2DM who were receiving antidiabetic medications achieved optimal HbA1C levels. It is recommended that additional education and support programs be provided to improve diabetes control and reduce its complications.

Iranian journal of diabetes and obesity
Islamic Azad University, Tehran (IR), Shiraz University of Medical Sciences (IR), Islamic Azad University Medical Branch of Tehran (IR), Islamic Azad University Pharmaceutical Sciences Branch (IR)
Good health and well-being
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon